- Business
- Oxford Instruments plc designs and manufactures high technology tools and systems for scientific research, industrial applications, and advanced manufacturing, serving academic, commercial, and government customers worldwide in sectors including materials analysis, semiconductors, healthcare, life sciences, and quantum technologies; core products and services encompass microscopy and imaging systems such as 3D/4D visualization software, confocal microscopes, analytical techniques for electron microscopy, scientific cameras, Raman imaging microscopes, and nanoindentation instruments including MEMS-based nanoindenters from FemtoTools AG; semiconductor process tools featuring plasma enhanced chemical vapour deposition (PECVD), inductively coupled plasma chemical vapour deposition (ICPCVD), atomic layer deposition (ALD), ion beam deposition (IBD), inductively coupled plasma etching (ICP RIE), reactive ion etching (RIE), deep silicon etching (DSiE), atomic layer etching (ALE), and ion beam etching (IBE); advanced technologies including superconducting magnet measurement platforms, cryogenic systems, X-ray tubes, benchtop NMR, X-ray fluorescence, optical emission spectroscopy, coating thickness gauges, MRI and CT systems, atomic force microscopy, and plasma processing equipment for VCSELs, photovoltaics, MEMS, optoelectronics, power, and RF devices; the company also provides maintenance, repair, spare parts, upgrades, training, and software solutions. Founded in 1959 and headquartered in Abingdon, Oxfordshire, United Kingdom, with principal manufacturing and operations in the UK, United States, Europe, China, and Asia, Oxford Instruments operates through two main segments: Imaging & Analysis, focusing on microscopy, cameras, analytical instruments, and software; and Advanced Technologies, covering compound semiconductor fabrication equipment, cryogenic and superconducting magnet technology, and X-ray sources. Recent developments include the January 2024 acquisition of First Light Imaging SAS to enhance scientific imaging capabilities; the acquisition of FemtoTools AG for nanoindentation technology; the June 2025 agreement to divest its quantum-focused NanoScience business to Quantum Design for £60 million cash, including up to £3 million deferred consideration, enabling sharper focus on core growth areas and funding a £100 million share buyback programme; a plasma modelling R&D collaboration with Quantemol supported by Innovate UK; delivery of automated 6-inch InP wafer processing systems to Coherent Corp. for AI applications; and the release of Imaris 11, its latest 3D/4D microscopy software, alongside local manufacturing of electron microscopy detectors in China for competitive advantage in that market.